Acne fulminans and 13-cis-retinoic acid.

J Dermatol

Department of Dermatology, Yonsei University Wonju College of Medicine, Korea.

Published: June 1992

We report a case of acne fulminans occurring during treatment with 13-cis-retinoic acid for cystic acne. Continuing the treatment with 13-cis-retinoic acid without systemic steroid eventually cleared the systemic manifestations and skin lesions. We review the literature and discuss its pathogenesis.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1346-8138.1992.tb03243.xDOI Listing

Publication Analysis

Top Keywords

13-cis-retinoic acid
12
acne fulminans
8
treatment 13-cis-retinoic
8
fulminans 13-cis-retinoic
4
acid report
4
report case
4
case acne
4
fulminans occurring
4
occurring treatment
4
acid cystic
4

Similar Publications

Effectiveness of Isotretinoin Administration in Rhinoplasty: A Systematic Review.

Facial Plast Surg Aesthet Med

January 2025

Division of Facial Plastic and Reconstructive Surgery, Stanford University School of Medicine, Stanford, California, USA.

To investigate the effectiveness of isotretinoin use in patients with thick nasal skin to improve rhinoplasty outcomes. The Population Intervention Comparison Outcome framework was utilized for selecting relevant studies for review. The databases of Medline, Embase, Cinahl, Central, Scopus, and Web of Science were searched in June 2024.

View Article and Find Full Text PDF

Introduction: Acne vulgaris, a prevalent dermatological condition, often results in long-term complications such as scarring and hyperpigmentation. While extensive research has focused on treatment modalities, there is a notable gap in understanding the factors contributing to the development of acne scarring and post-inflammatory hyperpigmentation (PIH).

Purpose: This study was conducted to identify the factors contributing to the development of acne scarring and post-inflammatory hyperpigmentation (PIH).

View Article and Find Full Text PDF

The pandemic of SARS-CoV2 is not only limited to the health issues and fatalities encountered in a worldwide overwhelming burden but also the social, economic, and well-being devastation. Many trials were done to find a safe and reliable therapy for COVID-19. Isotretinoin was reported as a possible therapy for COVID-19 through the mining of post-transcriptomic and genomic datasets, which revealed isotretinoin as a potent down-regulator of the ACE2 protein the crucial gateway of SARS-CoV2 to hijack host cells.

View Article and Find Full Text PDF

A comparison of iPLEDGE requirements to risk mitigation programs for isotretinoin in other countries and to other teratogenic medications in the United States.

J Am Acad Dermatol

January 2025

The George Washington University School of Medicine and Health Sciences, Department of Dermatology, Washington, DC 20052; Children's National Hospital, Division of Dermatology, Washington, DC 20010.

View Article and Find Full Text PDF

Background: Acne is an inflammatory skin disease afflicting the majority of the world's population at some point in their lifetime, and is seen to be chronic in about 50% of cases. Acne leads to significant social withdrawal, depression, and disfiguring scars in many cases. Available treatments are characterized by high rates of relapse, dangerous side effects, and social stigma, which often leads to poor patient compliance and treatment failure.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!